(Reuters) – GlaxoSmithKline sued Moderna in Delaware federal court on Tuesday for allegedly violating GSK’s patent rights in messenger RNA (mRNA) technology with its blockbuster COVID-19 vaccine Spikevax.
The lawsuit said Moderna’s lipid nanoparticles for transporting mRNA into the human body infringe several GSK patents covering similar innovations. GSK filed a related lawsuit against Pfizer and BioNTech in the same court in April over their COVID-19 vaccines.
(Reporting by Blake Brittain)
Comments